Plan: OPEN | Option: Growth | Sailesh Raj Bhan

11 Nov 19 | 12:00 AM

147.25 0.71 (0.48%)

  • Outperforms

    -4.00%

    Return (1Y)

    beaten by 5.34%

  • Less Volatile

    0.83%

    Standard Deviation (1Y)

    Lower than by -0.35%

  • Consistent

    7/12

    Months

    Has beaten

  • Value research rating

    Not Rated

Scheme Trivia

  • Reliance Pharma Fund (G) fund has been the 5th best in 5Y performance in the Equity - Pharma category

  • Reliance Pharma Fund (G) fund has been given the 4th best Risk adjusted performance for the past 5Y in the Equity - Pharma category

  • Reliance Pharma Fund (G) fund has been the 5th best in the 5Y SIP performance in the Equity - Pharma category

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year Nippon India Pharma Fund (G), has beaten its benchmark, by 5.34% (CAGR difference)

-4.00%

Outperforms

This is +ve Alpha

Performance Chart for Rs

Invested in

Risk

In last 1 year , the volatility of Nippon India Pharma Fund (G),is Lower than its benchmark, by -0.35%

0.83%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 7 out of Last 12 Months, i.e 58.33% of the times It has beaten its benchmark,

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, 3 Stocks beating the benchmark 15 Stocks not beating the benchmark

View Stock Composition